[go: up one dir, main page]

CY2022028I2 - HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES - Google Patents

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES

Info

Publication number
CY2022028I2
CY2022028I2 CY2022028C CY2022028C CY2022028I2 CY 2022028 I2 CY2022028 I2 CY 2022028I2 CY 2022028 C CY2022028 C CY 2022028C CY 2022028 C CY2022028 C CY 2022028C CY 2022028 I2 CY2022028 I2 CY 2022028I2
Authority
CY
Cyprus
Prior art keywords
transplantation
tumors
antibodies
treatment
autoimmune diseases
Prior art date
Application number
CY2022028C
Other languages
Greek (el)
Other versions
CY2022028I1 (en
Original Assignee
Viela Bio, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/077916 external-priority patent/WO2008031056A2/en
Application filed by Viela Bio, Inc. filed Critical Viela Bio, Inc.
Publication of CY2022028I1 publication Critical patent/CY2022028I1/en
Publication of CY2022028I2 publication Critical patent/CY2022028I2/en

Links

CY2022028C 2006-09-08 2022-09-13 HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES CY2022028I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84293506P 2006-09-08 2006-09-08
PCT/US2007/077916 WO2008031056A2 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Publications (2)

Publication Number Publication Date
CY2022028I1 CY2022028I1 (en) 2023-01-05
CY2022028I2 true CY2022028I2 (en) 2023-01-05

Family

ID=41104973

Family Applications (1)

Application Number Title Priority Date Filing Date
CY2022028C CY2022028I2 (en) 2006-09-08 2022-09-13 HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES

Country Status (3)

Country Link
CN (1) CN101534859B (en)
CY (1) CY2022028I2 (en)
SI (1) SI2066349T1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201909320UA (en) * 2015-04-06 2019-11-28 Regeneron Pharma Humanized t cell mediated immune responses in non-human animals
CN107793478B (en) * 2016-09-06 2023-05-02 华道(上海)生物医药有限公司 anti-CD 19 antibody and preparation method and application thereof
CN106599593B (en) * 2016-12-22 2019-03-26 贵州源熙生物研发有限公司 A kind of remodeling method of natural anti-cancer peptide
EA202090020A1 (en) * 2017-07-10 2020-04-28 Интернэшнл - Драг - Дивелопмент - Байотек TREATMENT OF B-CELL MALIGNANT NEW FORMATIONS USING AFUCHOSILED PROPAOPTOTIC ANTI-CD19 ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES OR CHEMOTHERAPEUTIC MEDICINES
EP3683229A1 (en) * 2019-01-21 2020-07-22 Charité - Universitätsmedizin Berlin Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy
MX2021012870A (en) * 2019-04-24 2022-01-18 Viela Bio Inc Use of an anti-cd19 antibody to treat autoimmune disease.
CN112578117B (en) * 2021-02-22 2021-05-25 信纳克(北京)生化标志物检测医学研究有限责任公司 Antibody composition and application thereof in screening post-transplantation lymphocyte proliferative diseases
CN114349863B (en) * 2022-03-21 2022-07-12 上海优替济生生物医药有限公司 anti-CD19 antibody and preparation method and application thereof
CN116516007B (en) * 2023-04-18 2024-01-19 华中科技大学同济医学院附属协和医院 Method for detecting CD19 expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012493A2 (en) * 2003-07-31 2005-02-10 Immunomedics, Inc. Anti-cd19 antibodies
EP1853718B1 (en) * 2005-02-15 2015-08-05 Duke University Anti-cd19 antibodies and uses in oncology

Also Published As

Publication number Publication date
SI2066349T1 (en) 2012-08-31
CN101534859A (en) 2009-09-16
CN101534859B (en) 2017-06-09
CY2022028I1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
CY2022028I2 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
CY2021009I2 (en) ANTI-P-SELECTIN ANTIBODIES AND METHODS OF USING THEM IN THE TREATMENT OF INFLAMMATORY DISEASES
CY2018013I1 (en) HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY2020021I2 (en) ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGUES AND METHODS OF USE
LTPA2017011I1 (en) Antibody against PDGFR-alpha for use in the treatment of tumors
HUE048404T2 (en) Monoclonal antibodies against Claudin-18 for the treatment of cancer
DK2222706T3 (en) ANTIBODIES AGAINST HUMAN NKG2D AND USES THEREOF
HK1223114A1 (en) Anti-factor xi monoclonal antibodies and methods of use thereof xi
IL197459A0 (en) Humanized proteins, including antibodies and methods for producing the same
HK1097859A1 (en) Anti-human antibodies and their uses
EP1998799B8 (en) Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
CY1112277T1 (en) HUMANIZED ANTI-β7 COMPETITORS AND THEIR USES
FI20075278A0 (en) Novel completely human anti-VAP-1 monoclonal antibodies
DK2907827T3 (en) Humanized anti-factor D antibodies and uses thereof
PL2177537T3 (en) Antibodies against MadCAM
DK1844074T3 (en) Human antibodies and proteins
HK1121041A1 (en) Novel use of anti il-1beta antibodies
EP1999148B8 (en) Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
ATE483732T1 (en) MADCAM ANTIBODIES
DK1976884T3 (en) Anti-ephrinb2 antibodies and methods for their use.
WO2010072740A3 (en) TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF
EP1793857A4 (en) COMBINED THERAPY WITH ANTI-CTLA4 AND ANTI-4-1BB ANTIBODIES
BRPI0509495A2 (en) humanized antibody
ITRM20040105A1 (en) MONOCLONAL ANTI-POCKET HUMAN ANTIBODY.
ATE518887T1 (en) ANTI-IGSF4 ANTIBODIES AND THEIR USE